glp 1 ad 👎 The GLP-1 startup making digital health look bad Novo Nordisk slammed with another

First-time prescribing of AOMs increased in June 2025, relative to March 2025 (+8.5%)

exporters competitiveness and foreign consumers relative purchasing power, while increasing domestic wine importers purchasing power

GLP-1 receptor agonists: Exploration of transformation from metabolic regulation to multi-organ therapy

If diet and exercise alone have not delivered the results you hoped for, oral GLP-1 therapy may be the structured support you have been looking for

Hers is a direct-to-consumer telehealth brand that helps people access GLP-1 medications for weight loss without the usual hurdles of lab work, referrals, or insurance approval